tm logo
SYNEURX
Live/Registered
REGISTERED

on 06 Mar 2018

Last Applicant/ Owned by

Zhongxiao E. Rd., Xinyi Dist.

Taipei City 110

TW

Serial Number

87090968 filed on 01st Jul 2016

Registration Number

5419035 registered on 06th Mar 2018

in the Principal Register

Correspondent Address

Paul Cosmovici

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SYNEURX

Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of nRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services


First Use Date in General

14th Mar 2016

First Use Date in Commerce

14th Mar 2016

Class [005]
Pharmaceutical Products


Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes


First Use Date in General

31st May 2014

First Use Date in Commerce

31st May 2014

Mark Details


Serial Number

No 87090968

Mark Type

No Service Mark

Attorney Docket Number

No 20248

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Feb 2024TEAS SECTION 8 RECEIVED
06th Mar 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
25th Jan 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25th Jan 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25th Jan 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
06th Mar 2018REGISTERED-PRINCIPAL REGISTER
31st Jan 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30th Jan 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
30th Jan 2018STATEMENT OF USE PROCESSING COMPLETE
30th Jan 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED